The diagnosis of prostate cancer is most commonly made by a triad of serum prostate specific antigen (PSA) measurements, digital rectal examination (DRE), and histological assessment of transrectal ultrasound (TRUS) guided biopsy material [5]. This evidence concerns the gene KLK3 and prostate carcinoma.